Description
Embecta Corp. is a global medical device company. The Company is focused on providing solutions to people living with diabetes.
The Company's portfolio of products include a variety of pen needles, syringes and safety devices, which are complemented by its digital applications designed to assist people with managing their diabetes. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with insulin pens and are used to inject insulin or other diabetes medications.
The Company also sells sterile, single-use insulin syringes, safety pen needles, which include resin injection-molded shields on both ends of the cannula that automatically help prevent needlestick exposure and injury during injection and disposal. Its products are used in retail and acute care hospitals, clinics and other institutional channels, healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.
